BioDundee International Conference
Registration is now open
Free Virtual Conference, Exhibition and Networking
Tuesday 17th May 2022
08:30 – 16:30 (BST)
The 21st BioDundee International Conference, accompanying exhibition and networking opportunity, will take place virtually on Tuesday 17th of May, 2022.
The BioDundee conference has been running for two decades and is the longest-running and most established event of its kind in Scotland. The Conference will be virtual and delivered in partnership with D C Thomson & Co Ltd. The conference shall be a one-day event with accompanying exhibition and networking opportunities attracting attendees and exhibitors from the UK, and International, Life Sciences, Healthcare, Digital, and associated sectors.
The title of the 21st BioDundee International Conference is ‘Life Sciences and Healthcare: Innovation, Collaboration and Growth’.
This year’s BioDundee Conference Committee is made up of members from the following organisations:
Dundee City Council
Dundee Volunteer and Voluntary Action
Henderson Loggie
Interface
Medtronic
Scottish Enterprise
Scottish Government
University of Dundee
For any event enquiries please contact becky.hendry@dctmedia.co.uk.
For any sponsorship opportunities please contact aimee.mitchell@dctmedia.co.uk.
For assistance or information surrounding the virtual platform Hopin, please click here.
Session 1 – Getting ready for global growth sponsored by Henderson Loggie
Finance giant, Henderson Loggie, is delivering the very first session on the extensive BioDundee programme which will focus on Finance & Investment. Beginning with a 30-minute, four-strong panel discussion – chaired by Henderson Loggie’s corporate finance partner Rod Mathers – the session is ideal for businesses looking to grow. Speakers include Anne Muir of the University of Dundee, Jan Robertson from Scottish Enterprise and Sarah Willis of Intelligent Growth Solutions. Each panelist will bring their expertise and knowledge as they pass on their learnings about research, investment and raising funding. Participants will also hear from Aidan MacMillan, senior investment manager at Par Equity, about why Scotland is a good place to invest, before a short question and answer session brings session one to an end.
Session 2 – Working together towards sustainability
We’re on a journey towards net zero in Scotland, and the Life Sciences and healthcare sectors are working together to help get there. This BioDundee session will emphasise the importance of industry and the NHS working together to make a significant contribution to the vital sustainability agenda. Virtual attendees will hear from experts including Simon Doherty (Institute of Global Food Security, Queen’s University Belfast), William Walker (Endocryne), Professor Colin Campbell (James Hutton Institute), Dr. Mark Bustard (IBIOIC) and Phillip McLean (Scottish Government), chaired by Dr. Marian Bruce (Highland Boundary Ltd, Kirklandbank Farm and Affric Highlands).
Session 3 – Innovation in the Life Sciences and Healthcare sectors sponsored by Research and Innovation Services (RIS), University of Dundee
Innovation has always played a key role in the Life Sciences and healthcare sectors, but how does innovation look in today’s world? This session will focus on the importance of collaboration and sharing of knowledge, ideas and experience when it comes to making impactful developments. Sponsored by Research and Innovation Services (RIS) at University of Dundee, confirmed panellists include Dr. Scott Cunningham (MyWay Digital Health and University of Dundee), Mairi Dillon (CPI (Enterprises) ), Pooja Jain (CogniHealth), Mairi Dillon (CPI), Chris Hillier (Southampton Business School and University of Southampton) and Andrew Fowlie (Scottish Health and Industry Partnership).
Session 4 – What’s next for MedTech in Scotland? sponsored by Scottish Health Innovations Limited (SHIL)
Sponsored by Scottish Health Innovations Limited (SHIL) and led by its head of innovation, Dr. Robert Rea, the ‘What’s next for MedTech in Scotland?’ session will cover a variety of timely issues and opportunities facing the health tech industry. From innovation and collaboration to the rise of AI, sustainability and the ever-changing regulatory framework, the focus will be on highlighting the unique attributes Scotland has to offer MedTech – including how our infrastructure can support innovation and attract investment. Dr. Robert Rea will be chairing a panel, all offering their expert insight to the discussion. This will include Professor Emanuele Trucco FRSA FIAPR FBMVA FAAIA (University of Dundee and Eye to the Future), Professor Colin Fleming (NHS Tayside), Dr. Ann Wales (Digital Health & Care Innovation Centre) and Peter Ellingworth (ABHI).
Session 5 – What the future holds? sponsored by Invest in Dundee and The School of Life Sciences, University of Dundee
The fifth and final session of the BioDundee International Conference 2022 will celebrate the importance of collaboration and partnership working as Scotland’s life sciences and healthcare sectors look to the future. This session also explores what the global trends will be and is jointly sponsored by Invest in Dundee and the School of Life Sciences at The University of Dundee. Both organisations are a major part of the city, its growth and its future. Alison Culpan, director of ABPI Scotland, will be chairing the panel discussions which will feature five guest speakers from across this thriving industry, including Professor Alessio Ciulli, director of the Centre for Targeted Protein Degradation at The University of Dundee. Malcolm Skingle, director of Academic Liaison at GlaxoSmithKine, and Mark Cook, Chair at ABHI Scotland and Vice Chair of Scotland’s Life Sciences Industrial Leadership Group, will also be speaking as well as Dr Harriet Teare, programme director at UK SPINE at The University of Oxford. Delegates will also hear from Surbhi Gupta, Senior Industry Analyst at Frost and Sullivan before the session closes.
Itinerary
| 08:30: | Arrival and networking |
| 09:00: | Introduction - Dr. Mhairi Towler, Founder and CEO, Vivomotion |
| 09:05: | Welcome Remarks - Professor Iain Gillespie, Principal & Vice-Chancellor, University of Dundee |
| 09:15: | Keynote Speaker - Adrian Gillespie, Chief Executive, Scottish Enterprise |
| 09:30: | Getting ready for global growth sponsored by Henderson Loggie |
| 10:00: | Session 1 Q&A |
| 10:15: | Refreshment Break - Networking and Exhibition |
| 10:45: | Working together towards sustainability |
| 11:15: | Session 2 Q&A |
| 11:30: | Refreshment Break - Networking and Exhibition |
| 12:00: | Innovation in the Life Sciences and Healthcare sectors – sponsored by Research and Innovation Services (RIS), University of Dundee |
| 12:30: | Session 3 Q&A |
| 12:45: | Lunch - Networking and Exhibition |
| 13:30: | What’s next for MedTech in Scotland? sponsored by Scottish Health Innovations Limited (SHIL) |
| 14:00: | Session 4 Q&A |
| 14:15: | Refreshment Break - Networking and Exhibition |
| 14:45: | What the future holds? sponsored by Invest in Dundee and The School of Life Sciences, University of Dundee |
| 15:15: | Session 5 Q&A |
| 15:30: | Closing Address - Dr. Mhairi Towler, Founder and CEO, Vivomotion |
| 15:45: | Conference content closes |
| 15:45: | Networking and Exhibition |
| 16:30: | Event Closes |
Introduction, Welcome, Keynote and Closing Address
-
Dr. Mhairi Towler
Founder and CEO, Vivomotion
-
Professor Iain Gillespie
Principal & Vice-Chancellor University of Dundee
-
Adrian Gillespie
Chief Executive, Scottish Enterprise
Session 1
-
-
Rod Mathers (Chair)
Corporate Finance Partner, Henderson Loggie
-
Aidan MacMillan
Senior Investment Manager, Par Equity
-
Anne Muir
Head of IP and Commercialisation, University of Dundee
-
Jan Robertson
Interim Director of Global Trade, Scottish Enterprise
-
Sarah Willis
CFO, Intelligent Growth Solutions
Session 2
-
-
Dr. Marian Bruce (Chair)
Director and Distiller at Highland Boundary Ltd. and Kirklandbank Farm, and Enterprise Manager for Affric Highlands
-
Dr. Mark Bustard
CEO, IBIOIC
-
Professor Colin Campbell
Chief Executive, James Hutton Institute
-
Simon Doherty
GlobalScot (Animal Health, AgriTech & Aquaculture), Institute of Global Food Security, Queen's University Belfast
-
Phillip McLean
Head of NHS Facilities and Environmental Sustainability, Scottish Government
-
William Walker
Managing Director, Endocryne
Session 3
-
-
Dr. Scott Cunningham (Chair)
Chief Technical Officer at MyWay Digital Health and Senior Lecturer at University of Dundee
-
Mairi Dillon
Investor Relationships Manager, CPI (Enterprises)
-
Andrew Fowlie
Executive Lead for Life Sciences, Health, Social Care and Industrial Innovation and SHIP, and Directorate of Economy and Health and Social Care, The Scottish Government
-
Chris Hillier
Principal Enterprise Fellow, Dept. of Strategy, Innovation, and Enterprise Southampton Business School University of Southampton
-
Pooja Jain
CEO & Founder, CogniHealth
Session 4
-
-
Dr. Robert Rea (Chair)
Head of Innovation, Scottish Health Innovations Limited
-
Peter Ellingworth
Chief Executive, ABHI
-
Professor Colin Fleming
Honorary Professor of Dermatology, Clinical Lead, NHS Tayside Innovation, NHS Tayside
-
Professor Emanuele Trucco FRSA FIAPR FBMVA FAAIA
UoD: NRP Chair of Computational Vision at Univ of Dundee, SSEN, Computing, and EttF (incorporation expected summer 2022): co-director and co-founder for Eye to the Future (spin-off)
-
Dr. Ann Wales
Programme Lead, Knowledge and Decision Support, Digital Health & Care Innovation Centre
Session 5
-
-
Alison Culpan (Chair)
Director, ABPI Scotland
-
Professor Alessio Ciulli
Professor of Chemical and Structural Biology and Director of the Centre for Targeted Protein Degradation, University of Dundee
-
Mark Cook
Chair Life Sciences Scotland, ILG; Vice Chair NHS Scotland, Pension Scheme; Chair, ABHI Scotland
-
Surbhi Gupta
Senior Industry Analyst, Frost&Sullivan
-
Malcolm Skingle CBE, DSc, PhD
Director, Academic Liaison, GlaxoSmithKline
-
Dr. Harriet Teare
Programme Director UK SPINE, University of Oxford
Event Sponsors
AMICULUM® is an independent global health communications and consultancy business that works with pharmaceutical, biotechnology and health technology companies across the world. Our specialist services include medical communications, healthcare learning, creative design, clinical and commercial consultancy, support for market access and digital engagement. AMICULUM supports products in a wide range of therapy areas and has teams that focus specifically on rare diseases and advances in genomic medicine.
Created in 2001, AMICULUM has grown steadily for the past 21 years and now employs over 330 people worldwide. We have teams based across multiple locations in New Zealand, China, Hong Kong, Singapore, UAE, Switzerland, UK and USA. We have a team based on the campus of the University of Dundee.
Visit AMICULUM website
AMICULUM® is an independent global health communications and consultancy business that works with pharmaceutical, biotechnology and health technology companies across the world. Our specialist services include medical communications, healthcare learning, creative design, clinical and commercial consultancy, support for market access and digital engagement. AMICULUM supports products in a wide range of therapy areas and has teams that focus specifically on rare diseases and advances in genomic medicine.
Created in 2001, AMICULUM has grown steadily for the past 21 years and now employs over 330 people worldwide. We have teams based across multiple locations in New Zealand, China, Hong Kong, Singapore, UAE, Switzerland, UK and USA. We have a team based on the campus of the University of Dundee.
Visit AMICULUM websiteHenderson Loggie has been serving Scotland and Scottish business for well over a century. Our vision is to be first choice in Scotland as a place to work and for our services to our clients.
Our purpose is to help our teams and our clients achieve their potential, to create wealth for the local economy now and to leave legacy for the future in the communities where we are located.
We have a specialist Lifescience sector team and have been involved with Bio-Dundee since its inception, we are proud to be sponsors of this year’s event.
Visit Henderson Loggie (BioDundee) websiteInvest in Dundee is an inward investor service delivered by Dundee City Council in partnership with local and national agencies. It aims to promote Dundee as a world class location for investment and to provide potential investors with information and support. With a regenerated waterfront, an international class design museum in V&A Dundee, a spectacular river setting, 2 industry focused universities, a commitment to green recovery and an affordable cost base, there has never been a better time to consider Dundee.
Visit Invest in Dundee websiteBridging academia and industry, Research and Innovation Services at the University of Dundee are key strategic drivers of innovation and commercialisation, offering opportunities to develop and grow your business through access to academic knowledge and resources.
We do this by:
Connecting local businesses to academic experts
Advising on opportunities to access funding, innovate and grow
Facilitating conversations and events that bring partnerships to fruition
Visit Research and Innovation Services, University of Dundee websiteThe School of Life Sciences at the University of Dundee is a world-class academic institution with a reputation for the excellence of its research, its high quality teaching and student experience, and the strong impact of its activities outside academia. With 700 staff from over 50 countries worldwide, the School provides a dynamic, multi-national, collegiate and diverse environment within which to train the next generation of scientists and innovators. We have extensive productive collaborations with industry and take effective interdisciplinary approaches to address complex biological questions. State-of-the-art technologies and extensive professional service support, underpin our ambitious research portfolio and world-changing impact successes.
Visit School of Life Sciences, University of Dundee websiteScottish Health Innovations Ltd (SHIL) works in partnership with NHS Scotland to identify, protect, develop and commercialise forward-thinking healthcare innovations that positively impact health, social and economic outcomes in Scotland.
Drawing on 20 years of operational experience, SHIL’s multidisciplinary team utilises specialised knowledge to help bring new ideas and innovations from healthcare professionals to life. Expert services including intellectual property advice and protection, regulatory expertise, project management, idea incubation, funding advice, development and commercialisation, and post-commercialisation monitoring.
SHIL believes ground-breaking ideas have the power to significantly improve health and social care for all, while supporting an ambitious, entrepreneurial, forward-thinking Scotland. Working collaboratively with the NHS, academia, industry, entrepreneurs and funders, we are committed to accelerating innovation and entrepreneurism across all areas of health.
Visit Scottish Health Innovations Ltd (SHIL) websiteExhibitors
Ambit is a talent consultancy business that provides high-growth life science SMEs with support that combines sustainable long-term recruitment strategies with the agility to meet immediate hiring needs. Our team offers international recruitment experience with cross-sector expertise and specializes in aligning talent with opportunity.
Ambit was launched in 2021 and is part of the AMICULUM family of agencies. We identified room for significant improvement in the recruitment support offered to growing companies and welcome enquiries from companies with the ambition to improve how they identify, attract and engage talented professionals.
Visit Ambit website